|
| | Donaldson et al. [5] | Salsamendi et al. [14] | Al Badri et al. [7] | Rajput et al. [15] | Fallon et al. [16] | Moriarty et al. [13] |
|
| Year | 2015 | 2015 | 2016 | 2020 | 2020 | 2021 |
| Patients (n) | 15 | 7 | 7 | 16 | 58 | 234 |
| Mean age (years) | 50 | 49.6 | 51.5 | 48 | 48 | 50.8 |
| Female sex (n) | 3 | 4 | 5 | 12 | 27 | 111 |
| Indication | Caval thrombus (n = 11) | Caval thrombus (n = 2) | IVC-associated mass (n = 3) | Right-sided intracardiac mass (n = 11) | Sterile thrombus (n = 30) | Right-sided intracardiac mass (n = 123) |
| | Pulmonary embolism (n = 5) | Fontan conduit and Glenn shunt mass (n = 1) | Pulmonary embolism (n = 2) | Catheter-associated thrombus (n = 7) | Cardiac device-associated vegetation (n = 8) | Catheter-associated thrombus (n = 25) |
| | Catheter-associated thrombus (n = 2) | Intracardiac mass (n = 4) | Catheter-associated thrombus (n = 2) | Caval thrombus (n = 9) | Chronic vascular access-associated vegetation (n = 16) | Caval thrombus (n = 91) |
| | | | | Concurrent pulmonary embolism (n = 7) | IVDU-related vegetation (n = 4) | Pulmonary embolism (n = 7) |
| | | | | | | Left-sided intracardiac mass (n = 1) |
| Location | RA (n = 11) | Vena cava (n = 2) | RA into RV (n = 4) | RA (n = 11) | SVC (n = 17) | SVC (n = 13) |
| | RV (n = 3) | PA (n = 2) | IVC (n = 3) | Vena cava (n = 9) | RA (n = 31) | RA (n = 98) |
| | | RA (n = 1) | | | TV/RV (n = 11) | TV (n = 14) |
| | | IVC (n = 1) | | | PA (n = 1) | RV (n = 4) |
| | | SVC (n = 1) | | | IVC (n = 24) | IVC (n = 1) |
| | | | | | Infrailiac (n = 8) | |
| Average size of the mass | NA | NA | NA | 4.1 cm | 3.2 cm | NA |
| Procedural success | 11 | 5 | 6 | 13 | 14 | 182 |
| Postprocedural complications | Bleeding (n = 11) | Hematoma (n = 3) | Cardiogenic shock (n = 1) | Transfusion without overt bleeding (n = 10) | Persistent or recurrent bacteremia (n = 11) | Bleeding (n = 9) |
| | Shock (n = 5) | | | Shock (n = 1) | Pulmonary embolism (n = 8) | Transfusion (n = 59) |
| | Hemodialysis (n = 3) | | | Hemodialysis (n = 2) | Persistent tricuspid regurgitation (n = 19) | Pulmonary embolism (n = 1) |
| | Liver failure (n = 2) | | | | | Persistent bacteremia (n = 1) |
| | | | | | | Stroke (n = 1) |
| | | | | | | Hematoma (n = 4) |
| | | | | | | Arrhythmia (n = 3) |
| Average LOS | 23 | NA | 20 | 13.82 | 16.84 | NA |
| Intraprocedural survival | 13 | 7 | 7 | 14 | 57 | 231 |
| Survival to discharge | 13 | 7 | 7 | 14 | NA | NA |
|
